4-Amino-2,6-dichloropyrimidine-5-carbaldehyde

Catalog No.: 
ACMSDC978
CAS No.: 
5971-68-6
Molecular Formula: 
C5H3Cl2N3O
Molecular Weight: 
192.01
4-Amino-2,6-dichloropyrimidine-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$120.00In stockInquiry
5g97%$420.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Amino-2,6-dichloropyrimidine-5-carbaldehyde
IUPAC Name4-amino-2,6-dichloropyrimidine-5-carbaldehyde
MDL No.MFCD12404980
Molecular FormulaC5H3Cl2N3O
Molecular Weight192.01
SMILESO=CC1=C(Cl)N=C(Cl)N=C1N
InChI KeyQVVGPFNVCJXVBI-UHFFFAOYSA-N
Synonym4-Amino-2,6-dichloropyrimidine-5-carboxaldehyde;4-amino-2,6-dichloropyrimidine-5-carbaldehyde;5-Pyrimidinecarboxaldehyde, 4-amino-2,6-dichloro-;6-Amino-2,4-dichloro-5-pyrimidinecarbaldehyde
CAS No.5971-68-6
PubChem CID45790851

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMSDC978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACSVPX047 route compound structure diagram
    ACSVPX04750270-27-4In Stock
  4. Then
  5. ACMSDC978 route product structure diagram
    ACMSDC9785971-68-6In Stock
Inquiry

2. ACMSDC978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMSDC978 route product structure diagram
    ACMSDC9785971-68-6In Stock
Inquiry

3. ACMSDC978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMSDC978 route product structure diagram
    ACMSDC9785971-68-6In Stock
Inquiry

Comments (0)